The foundation of our clinical rigor
Proven science drives everything we do. Through rigorous research, we demonstrate how our health technology delivers real results: better patient outcomes, greater value for healthcare systems, and more advanced AI capabilities. Key areas include:
Our AI transforms complex health data into personalized insights and guidance when individuals need it most.
We convert continuous glucose data into personalized guidance that elevates traditional diabetes care standards.
We address interconnected health conditions, turning digital engagement into measurable clinical improvements.
We offer FDA-cleared solutions for T1 and T2 diabetes that simplify treatment while addressing daily health challenges.
Personalized cardiometabolic care powered by artificial intelligence
Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control
The Impact of a Mobile Diabetes Health Intervention on Diabetes Distress and Depression Among Adults: Secondary Analysis of a Cluster Randomized Controlled Trial
Educators: Go Mobile & Join the Digital Revolution!
Mobile diabetes intervention study: testing a personalized treatment/behavioral communication intervention for blood glucose control
WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction
Type 2 Diabetes Hypoglycemia Prediction: Using SMBG Data & Probabilistic Methods
Mobile Diabetes Intervention for Glycemic Control: Impact on Physician Prescribing
Mobile Diabetes Intervention for Glycemic Control in 45- to 64-Year-Old Persons With Type 2 Diabetes
Lessons From a Community-Based mHealth Diabetes Self-Management Program: “It’s Not Just About the Cell Phone”
Hypoglycemia prediction using machine learning models for patients with type 2 diabetes
Enhancing Diabetes and Hypertension Self-Management: A Randomized Trial of a Mobile Phone Strategy
Evidence-Based mHealth Chronic Disease Mobile App Intervention Design: Development of a Framework
Mobile Messaging: It’s More Than Texting. A Mobile Message Taxonomy that Utilizes the Capacity of Mobile Technology
Expanding Reach: AADE7® Moves into the Digital Space
Older Adult Self-Efficacy Study of Mobile Phone Diabetes Management
Diabetes Digital Health Learning Network (DDHLN): Educators Designing the Future
CONNECTING PATIENTS AND DIABETES EDUCATORS VIA A MOBILE PHONE AND WEB-BASED TECHNOLOGY SYSTEM: Content Analysis of Portal Messages
Case Study: The IoT and Big Data in Healthcare Unleashing the Next Generation of Value Creation
Integration of a mobile-integrated therapy with electronic health records: lessons learned.
Combining the High Tech with the Soft Touch: Population Health Management Using eHealth and Peer Support
Measures derived from patient-generated health data provide insights on glycemic control beyond A1C for people with type 2 diabetes
Population Health Diabetes Education: The Role of Digital Health & Patient Generated Health Data
Transform Your DSME/S Program: Leverage the Value of Mobile Health
A Novel Economic Analysis Applied to Innovative Diabetes Digital Health Intervention Demonstrates Significant Financial Benefits
Improving Diabetes Self-Management with a Mobile App: Preliminary Results of a Pilot Program at a Safety Net Hospital System
For patients with type 2 diabetes, self-management remains a significant challenge. In recent years, the use of digital health technologies for chronic disease management has increased. In this study presented at the ADA 2020 Virtual Conference, patients with uncontrolled type 2 diabetes were analyzed using BlueStar® by Welldoc to determine mean changes in A1c.
Mobile Prescription Therapy: The Potential for Patient Engagement to Enhance Outcomes
Meet the Newly Revised AADE7 Self-Care Behaviors® Up Close
The AADE7 Self-Care Behaviors® (AADE7) provides a robust framework for self-management of diabetes and other related conditions. In this poster presented at ADCES 2020, the authors review AADE7 and make recommendations on behavior names.
An Effective Model of Diabetes Care and Education – Revising the AADE7 Self-Care Behaviors®
In this position paper from the American Association of Diabetes Educators (AADE), the authors evaluate the AADE7 within the framework of the advances in diabetes management as well as in diabetes self-management education and support.
A Data Science Framework for Mobile Health–Engagement and Outcomes
eHealth-Assisted Lay Health Coaching for Diabetes Self-Management Support
This project, supported by a Gillings Innovation Laboratory award at the UNC Gillings School of Global Public Health, tested the feasibility and reach of integrating a telephone-based lay health coach with an eHealth intervention for diabetes self-management support in a Patient-Centered Medical Home practice in New Jersey.
Blood Pressure Improvement in People Using a Digital Health Solution for Comprehensive Diabetes Self-management
A Framework for Optimizing Technology-Enabled Diabetes and Cardiometabolic Care and Education
This article published in The Diabetes EDUCATOR presents a framework for optimizing technology-enabled diabetes and cardiometabolic care and education using a standardized approach. The featured approach leverages the expertise of the diabetes care and education specialist, the multiplicity of technologies, and integration with the care team.
Are You Ready to Be an eEducator?
Health technology tools are redesigning clinical care and diabetes self-management education. In the article entitled, "Are You Ready to Be an eEducator?," the co-authors focus on the need for diabetes educators to move towards the implementation of digital health as a key delivery platform for diabetes education and care.
Development of Self-Management Behavior Scores and Profiles with Digital Health Data
Implementation Strategy for a Digital Health Tool Influences User Engagement
Published by the American Diabetes Association publication, this study by Welldoc authors examined the company's BlueStar® used in three different models: a healthcare provider model, a diabetes educator model and a health plan model to demonstrate how the implementation strategy has the potential to influence user engagement and outcomes.
Integrating The 2017 National Standards For Diabetes Self-Management Education And Support Into A Technology-Enabled Population Health Diabetes Care And Education Framework
Technology-Enabled Diabetes Self-Management Education & Support
Engagement With an AI-enabled Digital Health Tool by Individuals With Overweight or Obesity Enrolled in a Weight Management Program Differs by Use of Anti-obesity Medications
We investigated user engagement patterns within our digital health application, comparing individuals utilizing a weight management program both with and without anti-diabetic/anti-obesity medications (AOMs).
Studying engagement patterns is a key focus area for Welldoc as we continue to focus our research on further personalizing the weight management journey.
This research indicates that engagement can vary based on medication usage. We observed significantly higher engagement with the non-AOM group. This supports the idea that the need for tracking, guidance, and support needs may be more pronounced for individuals navigating their weight without these medications.
A Probability State Transition Matrix can be Used to Estimate Weight Loss for Individuals with Overweight or Obesity Enrolled in an AI-enabled Digital Health Weight Management Program
At Welldoc, our goal is to leverage these deep insights to build more personalized capabilities. By analyzing engagement across different clinical segments, we are developing AI models that can better predict individual needs and tailor digital coaching to truly support every unique path.
In this research, we studied the probabilities of weight loss, stratified by starting body mass index (BMI) band. We developed a probability state transition matrix to estimate the weight loss effect of a digital health tool on groups of individuals with and without an anti-obesity medication (AOM) in a weight management program.
In general, for users with starting BMI <36, use of the digital health tool proved to be an effective mechanism to lose weight without an AOM. When combined with engagement patterns, this research is foundational to developing AI-based weight loss prediction capabilities, based on both starting BMI level and the level of digital health engagement.
Food Detection from Continuous Glucose Monitoring Sensors Using Pretrained Transformer-Based Models
Nutrition is an essential component of managing chronic health conditions like diabetes and obesity. However, logging meals within health apps is time-consuming and cumbersome for many people. Welldoc continues to research opportunities to streamline this process through advanced AI.
In this research, we successfully developed a novel approach for automatedly detecting recent food intake solely based on continuous glucose monitoring (CGM) data and AI with an accuracy of 77.8%.
This research is a blueprint for the next generation of digital health. By enabling tools to gather consistent, complete dietary information without any input from the user, we are moving toward zero-effort self-management.
The Critical Elements of Digital Health in Diabetes and Cardiometabolic Care
In the latest issue of “Frontiers in Endocrinology,” Welldoc highlights key elements for designing and implementing successful diabetes digital health tools in clinical practice. We explore topics like the importance of regulatory oversight, looking beyond A1C, addressing technology literacy, and clinical integration to increase efficiency. Additionally, we outline the practical steps needed to become a digital health-ready practice. These insights are integral to Welldoc’s commitment to developing best-in-class digital health solutions and transforming the care continuum.
Technology to Overcome Therapeutic Inertia
In this issue of mHealth, the co-authors analyze the factors for why therapeutic inertia exists among those people battling Type 2 diabetes. The technology-enabled self-management feedback loop is presented as a more granular way to design studies to include technology interventions.
Safety of a Novel CGM-Informed Insulin Bolus Calculator Mobile Application by People with Type 1 and Type 2 Diabetes
Individuals with diabetes relying on basal-bolus insulin regimens often struggle with precise bolus dose adjustments. Current Continuous Glucose Monitoring (CGM) systems offer limited guidance, often relying on basic trend arrows. Building upon Welldoc’s extensive research on connecting digital health to CGM, Welldoc has developed a novel CGM-informed insulin bolus calculator. This advanced technology leverages sophisticated algorithms to analyze trend arrows and exercise factors, delivering real-time, personalized insulin dose recommendations.
This article outlines the results from a 30-day prospective clinical trial with participants with type 1 and type 2 diabetes. Participants experienced improved glycemic control and reduced diabetes distress, particularly for type 2 diabetes. Key findings include a notable Time in Range (TIR) improvement of approximately 3 points from 68.4 to 71.8% (N=54, P=0.013).
Welldoc’s CGM-informed insulin bolus calculator represents a significant advancement in diabetes management. By empowering individuals with diabetes to achieve better glycemic control and reduce the burden of the disease, our technology underscores the transformative potential of digital health when integrated with CGM.
Public-Private-Industry Learning Network: Digital Health Expands the Reach and the Role of the Diabetes Care and Education Specialist
Welldoc collaborated with the state of Montana and the Montana Diabetes Digital Health Learning Network (MDDHLN) to integrate digital health into their diabetes program. The intent was to scale services to better support Montana’s rural, frontier communities. This population typically has limited access to health resources and can benefit from innovative tools, like digital health platforms, to help better self-manage their diabetes. This article highlights the many learnings and best practices to efficiently and effectively implement novel cardiometabolic care models that integrate in-person, virtual and digital capabilities.
Interactive Digital Health: Engaging Healthy Behaviors & Clinical Outcomes
Incorporating smartphone technology into self-management activities for people with type 2 diabetes may improve patient outcomes. This study evaluates the impact of the FDA-cleared One Touch Reveal Plus® app powered by Welldoc's BlueStar® on BG control through a pre-post study of glucose control, participant engagement, and health care utilization and cost.
Integration of the Glucose Management Indicator (GMI) into the electronic health record through a diabetes-cardiometabolic digital health app
Health systems are increasingly integrating digital health solutions to provide personalized support to patients and timely insights to clinicians. The Allina Health system,, has partnered with Welldoc to integrate Welldoc’s FDA-cleared cardiometabolic digital app into their diabetes program. The Welldoc App syncs with continuous glucose monitoring (CGM) devices. This integration enables the system to capture a new metric, Glucose Management Indicator (GMI) to help support patients with diabetes. GMI is a calculated value based on CGM data that provides an estimate of a person's average blood sugar (A1C) over a shorter period. This is valuable because GMI can show changes in glucose levels faster than a traditional A1C test, which is helpful for both patients and clinicians. The poster outlines the GMI as a new metric for success in diabetes and key aspects of health system-health tech collaboration in diabetes.Key Takeaways:
- New Metric for Success: Welldoc is the first to utilize GMI as a quality metric within a digital health solution. The GMI is a calculated value used to estimate A1C based on CGM data. It provides a unique value in that it can be reported in a shorter time period (10-14 days) and allows for faster observation of glucose changes. The GMI's inclusion as a quality metric in the 2025 HEDIS measures recognizes the value of CGM data in assessing diabetes management.
- The power of health system-health tech collaboration: Allina and Welldoc partnered to effectively integrate the Welldoc solution into Allina’s diabetes program, which included workflow, eHR integration and incorporating data into clinical interventions and treatment plans.
- Eye on Quality of Care: The incorporation of GMI as a quality metric is essential for maintaining high Health Plan Ratings and Star ratings for value-based care. This integration helps health systems meet their quality goals and ultimately improves care for people with diabetes.
Individual Differences in Educational Engagement with a Digital Health Solution
This research, conducted by Welldoc in collaboration with the Robert H. Smith School of Business Center for Health Information and Decision Systems, evaluated the performance of a Welldoc automated method for detecting significantly adverse glucose events and, further, classifying those events by level of severity.
Impact of Food on A Transformer Based Glucose Prediction Model to Predict Glucose Trajectories at Different Time Horizons
In this research, Welldoc and Johns Hopkins Carey Business School leveraged dense, real-time glucose data from Continuous Glucose Monitoring (CGM), similar to how fitness trackers collect biometric signals. Our work shows that by combining this data with food intake, we can significantly improve the accuracy of future glucose predictions. This takes Welldoc one step closer to the real world application of reliable prediction and prevention of overnight hyperglycemia.Why It Matters:
- Smarter Predictions: We developed a "large health model" (LHM) that uses AI to analyze dense data from CGMs and food intake data. This model is more accurate in predicting future glucose levels over longer periods, with a greater improvement for the 2-hour interval when food's impact is highest. This improved accuracy is critical to establishing trust in the next generation of AI driven digital health coaching capabilities.
- Better Health Outcomes: This work establishes a clear pathway for integrating various types of health data into AI models to enhance their predictive power. The ultimate goal is to apply this improved accuracy to real-world clinical challenges, such as reliably predicting and preventing overnight hyperglycemia.
- A New Approach: Welldoc’s research goes beyond existing models by not only collecting data but also using it to predict future biometric values and offer automated coaching based on those predictions. This is a novel approach that leverages the power of AI to provide actionable insights for.
Impact of a Combined Continuous Glucose Monitoring–Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study
In this journal article, Welldoc builds upon prior research focused on advancing chronic care through the use of digital health and real-time connected devices. This study examines the impact of combing real-time continuous glucose monitoring (RT-CGM) with an AI-driven digital health solution on helping individuals with type 2 diabetes to improve their glycemic metrics like time in range (TIR).
Identifying Digital Health Habits Correlated with Improved Blood Glucose Control
This research, conducted by Welldoc in collaboration with the Robert H. Smith School of Business Center for Health Information and Decision Systems, evaluated the performance of a Welldoc automated method for detecting significantly adverse glucose events and, further, classifying those events by level of severity.
Human vs. Machine: A Comparative Study on CGM Event Detection and Classification
This research, conducted by Welldoc in collaboration with the Robert H. Smith School of Business Center for Health Information and Decision Systems, evaluated the performance of a Welldoc automated method for detecting significantly adverse glucose events and, further, classifying those events by level of severity.
From Data to Outcomes: Digital Health & the Role of the Healthcare Provider
For this study presented at the Academy Health Health Datapalooza, the authors presented the Digital Health Engagement Chain as a framework to assess each of the implementation approaches were used. Evaluations included the target population, the outreach modalities, and activation rate for each type of implementation: direct to consumer, a program approach, a healthcare provider (HCP), direct to patient, and a HCP via an electronic medical record (EMR) integration.
Examining The Ability of Different Machine Learning Approaches to Predict Health Outcomes with a Digital Health Platform
In this study, Welldoc builds upon our prior research on advancing digital health AI through machine learning (ML) and connection with real-time connected devices, such as continuous glucose monitoring (CGM). This study examines how CGM data combined with digital health My E-Diary for Activities and Lifestyle (MEDAL) data and behavior patterns can lead to better understanding of optimal digital health feature utilization and ML models, which can be used to predict future Time in Range (TIR). This research continues Welldoc's efforts in advancing our AI models and developing next generation digital health solutions geared towards personalized prevention and prediction.
Evaluating the Impact of a Combined Real-Time CGM/Digital Health Solution on Glucose Control for People with Type 2 Diabetes
Welldoc®, a digital health leader revolutionizing chronic care, today announced the presentation of data at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), evaluating how the combination of real-time CGM (rtCGM) with a digital health solution impacts glucose control for individuals with Type 2 diabetes not treated with insulin. For all participants and subgroups that were examined, the time in range (TIR) and glucose management indicator (GMI) improved significantly, demonstrating that a combined CGM and digital therapeutic solution has the potential to improve Type 2 diabetes management and glycemic control.
Evaluating a State-of-the-art Generative Pre-trained Transformer Model to Predict Continuous Glucose Monitoring Values at Different Time Intervals
Welldoc is actively developing generative-AI models specific to continuous glucose monitoring (CGM) value prediction. Our GPT-like AI modeling approach, based on a vast CGM dataset for individuals with type 1 and type 2 diabetes, has achieved state-of-the-art performance in predicting short-term CGM trajectories, at five-minute intervals, up to two hours in advance. Specifically, when predicting one of the 5 glucose categories (VeryLow, Low, InRange, High, VeryHigh), the model demonstrated an overall accuracy of 94% in predicting CGM values within 30 minutes. The absolute prediction accuracy to predict glucose values within 5mg/dL and 10 mg/dL error range in 30mins was 62% and 80% respectively. This exceptional accuracy highlights the model's potential to provide valuable insights into the dynamic interplay between blood sugar levels, lifestyle factors, and interventions. By leveraging these insights, personalized, automated coaching can be developed to optimize diabetes management and improve individual outcomes. This work is integral to Welldoc’s Advanced AI and our ability to transform the care continuum.
Evaluating Perplexity and Glucose Level Impact on State-Of-The-Art Generative Pre-trained Transformer (GPT) Model to Predict Glucose Values at Different Time Intervals
Welldoc continues to research how generative-AI models can be used in combination with data from real-time devices like continuous glucose monitors (CGM) to predict metrics like glucose risk indicator (GRI) and future health outcomes. Here, Welldoc developed a state-of-the-art GPT model to predict CGM trajectory at different time horizons and across two different prediction contexts. One particular context included model perplexity, which is an industry-standard metric of how well a model can predict a sample or next value in a sequence. The data show higher prediction uncertainty as the glucose profile complexity increases. This work supports Welldoc’s efforts to further optimize our diabetes solution, making the experience for individuals even more targeted and personalized.
Estimating the Economic Value of a Digital Therapeutic in Type 2 Diabetes
Truven Health Analytics, part of IBM Watson Health, conducted an analysis of commercial and Medicare consumers within the MarketScan databases for Welldoc. The research findings show Welldoc's ability to help lower and control A1C and generate savings per user per month.
Enhancing Mobile Health to Achieve Both Hypertension and Diabetes Goals
Meeting goals for hypertension, a common co-morbidity with Type 2 diabetes (T2D), can be a challenge. In this study, data from patients with T2D who activated BlueStar® by Welldoc were analyzed as a way to illustrate the potential for digital solutions to support patients for both type 2 diabetes and blood pressure.
Early Engagement Measures Can Accurately Identify Users at Risk of Abandoning Digital Therapeutics
The purpose of this research study was to develop a predictive model of digital health persistence and explore important factors in identifying those who are likely to abandon a digital therapeutic.
Digital Health and AI: RDN Path to Success
Cardiometabolic digital health solutions, which address conditions like diabetes, are increasingly being integrated into clinical care. These solutions can provide personalized artificial intelligence (AI)-driven self-management support for individuals and treatment insights for clinicians. Understanding how to effectively integrate these technologies into an individual’s daily experience and the clinician’s workflow is essential. Successful implementation of these solutions can improve reach, access and outcomes for health and operational efficiencies at the individual and population levels. This article discusses these solutions and shares real-world examples of strategies for integrating them into clinical practice.
Thank you to Cutting Edge Nutrition and Diabetes Care for providing open access to our article. To purchase and read the full issue, please visit the journal’s website.
Determinants of Engagement in Digital Health: What Makes it Stick?
Unveiled at the 2018 Diabetes Technology Meeting, the co-authors presented results of a study conducted on the determinants of digital health engagement among patients of a primary care clinic in Boston, MA. The authors sought to systematically assess patient characteristics that influence uptake or attrition.
Contextual Annotations Predict Digital Health Solution Persistence and Diabetes Outcomes
The purpose of this research, presented at the Diabetes Technology Society, was to explore how patients use annotation features, the relationship between annotations and persistent engagement, and diabetes outcomes through patient-generated annotations.
Consistent Engagement with a Digital Health Solution Enhances the Effect of Medication Changes on Blood Glucose Control
This research, conducted by Welldoc in collaboration with the Robert H. Smith School of Business Center for Health Information and Decision Systems, evaluated the performance of a Welldoc automated method for detecting significantly adverse glucose events and, further, classifying those events by level of severity.
Complementarity of Digital Health and Peer Support: “This Is What’s Coming”
This collaborative study, with Dr. Edwin Fisher PhD of University of North Carolina, Peers for Progress and Vanguard Medical Group, assess the effectiveness of the Welldoc solution and peer support in providing health management and education for adults with Type 2 Diabetes.
Comorbidities And Reducing InEquitieS (CARES): Feasibility of self-monitoring and community health worker support in management of comorbidities among Black breast and prostate cancer patients
Black individuals with cancer often face poorer health outcomes compared to other racial groups in the U.S., including a higher prevalence of cardiometabolic comorbidities, like diabetes and high blood pressure. A study published in Contemporary Clinical Trials Communications explores the potential of digital health tools to address these health disparities.
The study investigated the feasibility of incorporating the Welldoc cardiometabolic digital health app to improve blood pressure and/or blood glucose levels in Black individuals with breast or prostate cancer. Participants in this six month study used a home-monitoring device and the Welldoc app to track their health metrics weekly, with support from a community health worker.
While the study findings were modest, they suggest that digital health tools may be beneficial in helping individuals manage their overall health during cancer treatment. Further research is needed to optimize the integration of cardiometabolic health and digital health tools into cancer care, aiming to improve patient outcomes and reduce health disparities.
CGM-GPT: A Transformer Based Glucose Prediction Model to Predict Glucose Trajectories at Different Time Horizons
Welldoc is pioneering the use of AI to revolutionize diabetes management. Our groundbreaking general purpose transformer based CGM research represents a significant leap forward in predicting glucose levels for individuals living with both Type 1 and Type 2 diabetes.
This research is the first in a series outlining Welldoc's novel methodology towards predicting future continuous glucose monitoring (CGM) glucose levels with high accuracy. The poster presents Welldoc's state-of-the-art AI models, which can predict glucose trajectories at 30-, 60- and 120-minute intervals for both type 1 and type 2 diabetes populations with ~ 50% less root mean square error, when compared to existing benchmark studies. Welldoc's GPT model, CGM-GPT, was trained only on CGM data sets from individuals living with Type 1 and Type 2 diabetes, and reflects the advanced opportunity to develop sophisticated large sensor models (LSM) by leveraging the vast data available via real-time sensors.
We are committed to further refining our models by incorporating additional data sources and exploring expanded applications. This ongoing research will drive the development of innovative diabetes management solutions. Stay tuned for additional information on our exciting transformer based CGM research.
Applying the Glycemia Risk Index (GRI) to User Data from a Digital Health Tool Reveals Patterns of Engagement That Differ by Type of Diabetes
Welldoc® and the Carey Business School of Johns Hopkins University (formerly CHIDS at University of Maryland) continue to research how a digital health solution, combined with CGM data, can help individuals living with diabetes improve lifestyle factors and support better glycemic outcomes. In this study, we applied the Glycemia Risk Index (GRI) metric to assist with the basic clinical interpretation of CGM data. Our findings show that the average individual with type 1 and type 2 diabetes improved their GRI by 6 points during the first 14 days of use of the combined CGM and digital health tool. Individuals with type 2 diabetes that engage in digital health features like medications and lifestyle increased the probability of improved GRI, whereas individuals with type 1 diabetes saw improvement based on CGM wear time. The continued use of the GRI metric will help us demonstrate self-management and behavior outcomes of individuals using a combination of a digital health solution and CGM while extending support for diabetes populations.
Beyond Tracking: The Benefits of Contextual Annotation in a Diabetes Digital Therapeutic
Digital therapeutics can help patients manage chronic conditions by leveraging structured data like blood glucose, diet, and medication adherence, as well as unstructured data. The purpose of this study, presented at an American Diabetes Association session, was to develop a lexicon to characterize annotations made by patients using Welldoc's BlueStar® solution.
An Approach for Evaluating and Visualizing CGM Data in People with Diabetes
This research, conducted by Welldoc in collaboration with the Robert H. Smith School of Business Center for Health Information and Decision Systems, evaluated the performance of a Welldoc automated method for detecting significantly adverse glucose events and, further, classifying those events by level of severity.
A Systematic Review of Reviews Evaluating Technology-Enabled Diabetes Self-Management Education and Support
Since the introduction of web-enabled mobile devices, technology has been increasingly used to enable diabetes self-management education and support. This timely systematic review summarizes how currently available technology-enabled diabetes self-management solutions impact outcomes for people living with diabetes.
A Real-Time CGM-Enabled Digital Health Tool Highlights a Relationship Between Sentiment and Diabetes Distress in People Using Bolus Insulin
Welldoc continues to focus our research on advancing digital health through connection with real-time connected devices, such as continuous glucose monitoring (CGM). Building on prior clinical research, which showed an improvement in glucose outcomes and reduction in diabetes distress with the use of an app-based CGM-informed insulin bolus calculator, this study demonstrates qualitatively how these same individuals interacted with the technology and how it made them feel. People with type 1 and type 2 diabetes who inject bolus insulin often find their diabetes to be overwhelming. Here, Welldoc found there was a significant proportional connection between those who felt less distress about their diabetes and felt positively about the technology, versus those who felt more distressed. This research reinforces the power of combining digital health with CGM in not only supporting individuals with a more personalized digital health solution that they enjoy using, but also providing clinicians with additional tools to support people with diabetes distress management.
A Proposed Foundational Architecture for AI-powered Digital Health Platforms
Advancements in artificial intelligence (AI) are providing a wealth of opportunities for improving clinical practice and healthcare delivery. In this clinical presentation, we discuss principles that govern the responsible adoption of AI capabilities in healthcare to complement, not replace, the clinician.
Leveraging AI to drive better health care is complex, requiring diligence in operationalizing extensive and diverse data sets, clinical evidence, data governance, interoperability and a data intelligence platform that ensures privacy, security and scalable application in real-world settings. Examples are shared from Welldoc's digital health platform using generative AI features with the goal of transforming the care continuum from prevention through diagnosis, treatment, and ongoing management, including efficient acute care interventions when needed.
A Payer Digital Health Study Shows Scalable Approach to Cost Savings and Outcomes
Health plans must find a scalable solution that reduces healthcare use and costs among those with chronic conditions. This study from Aetna/CVS Health, Welldoc, and LifeScan explores health plan strategies that take advantage of digital health relative to outcomes.
A Novel Approach to Estimating Cost Savings and Return on Investment (ROI) for Weight/BMI Changes with Digital Health
Obesity is a costly condition. Welldoc is able to shift the BMI curve through digital health engagement alone – translating to significant ROI and cost savings. Here, we presented a modeling tool to show the ROI and economic impact of shifting individuals with obesity into a lower BMI band and our ability to do so through AI-driven digital health.Key Takeaways:
- ~25% of individuals with obesity successfully shifted to a BMI below 30
- $1,527 reduction in estimated average cost per person at 6 months
This was achieved without GLP-1 medications, highlighting how AI-driven digital health can be used in multiple ways to support weight management – as a standalone solution, or a precursor or adjunct to more costly treatment pathways.
A Novel Automated AI Method for Detecting and Classifying CGM Patterns
This research, conducted by Welldoc in collaboration with the Robert H. Smith School of Business Center for Health Information and Decision Systems, evaluated the performance of a Welldoc automated method for detecting significantly adverse glucose events and, further, classifying those events by level of severity.
A Novel Approach to Assess Patient Burden Using Data from a Digital Therapeutic for Type 2 Diabetes Predicts Glucose Outcomes
Digital therapeutics can help patients manage chronic conditions while presenting opportunities to assess and possibly alleviate certain treatment burdens. The purpose of this study, presented at the American Psychological Association, was to determine how digital therapeutics can assess patient burden associated with diabetes outcomes.
A Mobile App to Improve Self-Management of Individuals With Type 2 Diabetes: Qualitative Realist Evaluation
In this study from the Journal of Medical Internet Research, a Web-based solution was evaluated for improving self-management in type 2 diabetes (T2DM) patients. The study aims to identify key combinations of contextual variables and mechanisms of action that explain for whom the solution worked best and in what circumstances.
A Dynamic Duo: Virtual DSMES and a Digital App, a New Model for Self-Management Education
A Digital Health Solution with a CGM-informed Insulin Calculator Reduces Diabetes Distress in Individuals with Type 1 and Type 2 Diabetes
A digital health solution that assists people with diabetes self-management and insulin dosing may reduce diabetes distress, particularly around their treatment regimen and interpersonal relationships.
Let’s partner to elevate cardiometabolic health.
Contact our sales team to talk about a solution for your enterprise or request a demo to see Welldoc’s predictive AI in healthcare in action.
.png)
.avif)